loader2
Partner With Us NRI

Shalby Ltd share Price Today

Company details

287.10
297.85
178.40
339.50
6M Return -3.68%
1Y Return 62.15%
Mkt Cap.(Cr) 3,109.61
Volume 198,369
Div Yield 0.41%
OI
-
OI Chg %
-
Volume 198,369

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Healthcare Facilities company Shalby announced Q1FY25 results:

Consolidated:

  • Revenue at Rs 2,886 million in Q1FY25 vs Rs 2,400 million in Q1FY24 grew by 20.2% YoY
  • EBITDA at Rs 549 million in Q1FY25 vs Rs 477 million in Q1FY24 grew by 15.1% YoY
  • PBT at Rs 304 million in Q1FY25 vs Rs 330 million in Q1FY24
  • PAT at Rs 147 million in Q1FY25 vs Rs 208 million in Q1FY24
  • Net debt stood at Rs 1,680 million as on June’24
  • Annualized ROCE for Q1FY25 stood at 13.6%

Standalone:

  • Revenue at Rs 2,402 million in Q1FY25 vs Rs 2,163 million in Q1FY24 grew by 11.06% YoY
  • EBITDA at Rs 581 million in Q1FY25 vs Rs 497 million in Q1FY24 grew by 16.6% YoY
  • PBT at Rs 458 million in Q1FY25 vs Rs 400 million in Q1FY24
  • PAT at Rs 305 million in Q1FY25 vs Rs 262 million in Q1FY24
  • Net cash stood at Rs 627 million as on June’24
  • Annualized ROCE for Q1FY25 stood at 16%

 

Result PDF

 

View Other Company Results

Shalby Ltd shares SWOT Analysis

Strengths (9)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Effectively using its capital to generate profit - RoCE improving in last 2 years
  • Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Weakness (2)

  • Declining profits every quarter for the past 3 quarters
  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (0)

Data not found

Threats (1)

  • Increasing Trend in Non-Core Income

Resistance and support

R1 294.8
R2 301.7
R3 305.6
Pivot

290.95

S1 284.1
S2 280.2
S3 273.3
EMA SMA
282.9
277.0
274.5
263.0
281.3
274.2
269.2
279.3
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
EQUITY INTELLIGENCE INDIA PRIVATE LIMITED Bulk Purchase 2023-03-28 117 610000 NSE
SHALBY LIMITED EMPLOYEES WELFARE TRUST Bulk Purchase 2022-05-30 107.5 700000 NSE
SHALBY MEDICOS TRUST Bulk Sell 2022-05-30 107.5 700000 NSE
Name Category Shares
VIKRAM INDRAJIT SHAH PROMOTER 7.39%
DARSHINI VIKRAM SHAH PROMOTER 2.79%
SHAH FAMILY TRUST THROUH DR. VIKRAM SHAH, TRUSTEE PROMOTER 34.73%
ZODIAC MEDIQUIP LIMITED PROMOTER 29.21%

OUR RESEARCH VIEW

Investment recommendation
Focused approach, long-drawn strategy to the fore…
Call Date
08 Apr 2024
Entry Price 266.00
Target Price 320.00
Duration
12 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Shalby Ltd Stocks COMPARISON

Financials( in Cr) Shalby Ltd Apollo Hospitals Enterprise Ltd Max Healthcare Institute Ltd Fortis Healthcare Ltd Global Health Ltd
Price 287.90 6,353.90 900.50 480.40 1,212.35
% Change 0.91 -0.34 -0.78 2.19 -3.19
Mcap Cr 3,109.61 91,359.55 87,520.68 36,268.18 32,552.45
Revenue TTM Cr 804.92 16,612.50 4,831.37 6,537.06 2,280.01
Net Profit TTM Cr 67.68 887.50 1,103.51 632.98 360.89
PE TTM 39.85 101.81 82.72 61.78 68.03
1 Year Return 62.15 23.18 46.98 48.89 74.78
ROCE 10.35 14.16 13.85 7.51 17.19
ROE 7.50 15.04 16.12 6.79 13.52
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 927.69 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 22,113.01 47,751.14
LAST 3M 106,765.53 39,098.02
LAST 6M 194,925.52 15,119.67
LAST 12M 309,990.82 82,593.30
Shalby Limited - Copy of Newspaper Publication

Jul 09, 2024 l NSE Announcement

Board Meeting for Today

Jul 08, 2024 l Board Meetings for Today

NSE Board Meetings Forthcomming

Jul 08, 2024 l NSE Board Meetings Forthcomming

Date Action Type Ratio
Aug 08, 2023 Dividend 12
Sep 19, 2022 Dividend 10

Shalby Ltd Information

Stock PE (TTM)
39.85
Promoter Holding
74.25%
Book Value
92.674
ROCE
10.35%
ROE
7.5%
Description
  • Shalby Ltd was originally incorporated as a Private Limited Company with the name `Shalby Hospital Private Limited` on August 30, 2004. Subsequently, the Company was converted to a Public Limited Company and the name was changed to `Shalby Hospital Public Limited` on May 15, 2006. Further, the name of the Company was changed to Shalby Hospitals Limited on July 26, 2006 and then, again changed to Shalby Limited on February 13, 2008. Shalby Limited is an Ahmedabad-headquartered and one of the leading multi-specialty chain of hospitals in India and provides high-quality and economical healthcare services. The Hospitals are tertiary care hospitals, few of which also offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations. Led by Dr. Vikram Shah, an orthopaedic surgeon, the Hospital has grown from a single hospital to a chain of multi-specialty hospitals. Apart from a focus on orthopaedics, the hospitals provide advanced levels of care across various specialties such as neurology, cardiac care, critical care, oncology, and nephrology. The Hospitals, Krishna Shalby, SG Shalby, Shalby Indore and Shalby Jabalpur are accredited by the NABH. Further, Krishna Shalby and SG Shalby are also accredited by the NABL. The Hospital currently runs a pan-Indian chain of 11 multispecialty tertiary hospitals and 4 Single specialty Hospitals (SOCE) across 6 states with a total bed capacity of more than 2,000. Shalby has 59 outpatient clinics (OPDs) across 16 states. It also expanded global presence by opening OPDs in Kenya, Nairobi, Ethiopia, Tanzania, and Uganda in the African continent. In 2007, the Company established operations of its first multi-specialty hospital, SG Shalby, at Sarkhej Gandhinagar Highway in Ahmedabad. The company commenced a new hospital Shalby Vapi at Vapi in April 2012 and thereafter it commenced a new hospital Krishna Shalby in Ahmedabad in October 2012. The company commenced a new hospital Shalby Jabalpur at Jabalpur in Madhya Pradesh in March 2015. The company commenced a new hospital Shalby Indore at Indore in August 2015. In 2016, the company executed a memorandum of understanding with ZH Private Limited to manage and operate Zynova Shalby. During the year under review, the company executed an O&M agreement with Kamesh Hospital to commence operations of Shalby Mohali. In 2017, the company entered into an agreement with Bait Al Batterjee Medical Company LLC, Dubai, to provide outpatient orthopaedics and spine surgeries. The Company came up with an Initial Public Offer of 20,354,838 Equity Shares by raising capital from public aggregating to Rs 504. 8 Crores comprising a Fresh Issue of 19,354,838 Equity Shares amounting to Rs 480 Crores and an Offer for Sale of 1,000,000 Equity Shares amounting to Rs 24.8 Crore in December, 2017. With the increase in demand of digital transformation in healthcare sector, Shalby embarked its journey of digital transformation across its all hospitals from 2018-19. In 2020, the Company launched Video Assisted Thoracic Surgery (VATS) to reduce the incidence of surgical complications. The Liver Transplant Facility became fully operational at Shalby, Ahmedabad and Mohali. The Company incorporated a new wholly owned subsidiary Company under the name and style `Mars Medical Devices Limited` on April 3, 2020. The Company also incorporated wholly-owned subsidiary company under the name and style `Shalby Hospitals Mumbai Pvt. Ltd.` on December 10, 2020. In May 2021, the Company acquired the assets of Consensus Orthopaedics, a hip and knee implant manufacturing company with its facility at El Dorado Hills, USA. The Company also commenced multi-speciality rehabilitation centre at one of its Unit in 2021. The Company launched a state-of-the-art `Digital Spine Operation Room` at SG Shalby Hospital, Ahmedabad in 2022. In September 2021, the Company launched its first Shalby Orthopedics Centre of Excellence (SOCE) in the country at Udaipur. Centralised cloud based Laboratory Information System (LIS) was launched in 2022. The Company further incorporated Shalby Advanced Technologies Inc. (SAT) in the first quarter of Fiscal 2022. In 2022-23, the Company launched a new product line of Uni Knee System called as Tahoe Unicompartmental Knee System or TUKS.

Registered Address

Opp Karnawati Club, Sarkhej Gandhinagar Highway, Ahmedabad, Gujarat, 380015

Tel : 91-79-40203000
Email : companysecretary:shalby.in
Website : http://www.shalby.org
Registrar

KFin Techologies Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 540797
NSE Code : SHALBY
Book Closure Date (Month) : Aug
BSE Group : B
ISIN : INE597J01018

FAQ’s on Shalby Ltd Shares

You can buy Shalby Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Shalby Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 12, 2024 04:04 PM the closing price of Shalby Ltd was Rs.287.90.

The latest PE ratio of Shalby Ltd as of Jul 12, 2024 04:04 PM is 39.85

The latest PB ratio of Shalby Ltd as of Jul 12, 2024 04:04 PM is 0.32

The 52-week high of Shalby Ltd share price is Rs. 339.50 while the 52-week low is Rs. 178.40

According to analyst recommendations, Shalby Ltd Share has a "Buy" rating for the long term.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 12, 2024 04:04 PM, the market cap of Shalby Ltd stood at Rs. 3,109.61 Cr.

Download App

Download Our App

Play Store App Store
market app